Welcome to Nordic Society of Gynaecological Oncology


Study documentation (link to documents, only accessible with password to www.nsgo.org).

Click HERE for access.

Study sponsorNSGO
NSGO Project Manager

Mette Engell
NSGO, Rigshospitalet, Copenhagen, Denmark.
+45 3545 3389

Study Chair

Mansoor Raza Mirza
NSGO, Rigshospitalet, Copenhagen, Denmark
+45 3545 9624

Drug Durvalumab and MEDI9447
Phase II
Randomized trial No
Type Open-label
Total number of patients 25 patients required 
Number of patients recruitedRecruitment statistics – link
Trial statusRecruitment closed
Date of first site activatedMarch 2018
eCRFOpen Clinica test – link (protected information – access only with login)
Open Clinica Live –link (protected information – access only with login)
Site listSite list – Not available. Will be added soon.
Protocol summaryClinicalTrials.gov – link

Click HERE for access.